Fidelity Select Medical Tech and Devcs holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Fidelity Select Medical Technology and Devices Portfolio FSMEX
- NAV / 1-Day Return $55.69 / +0.50 %
- Fund Size $3.5B
- Adjusted Expense Ratio 0.620%
- Net Expense Ratio 0.620%
- Fee Level: Distribution Low
- Share Class Type No Load
- Morningstar Category Health
- Equity Style Box (Funds) Mid Blend
- Minimum Initial Investment $0
- Investment Status Open
- TTM Yield 0.00%
- Turnover Ratio 54%
Morningstar’s Analysis FSMEX
Will FSMEX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 63.4
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Thermo Fisher Scientific Inc | 17.59 | 589M | Healthcare |
Danaher Corp | 14.04 | 470M | Healthcare |
Intuitive Surgical Inc | 5.29 | 177M | Healthcare |
Waters Corp | 4.27 | 143M | Healthcare |
West Pharmaceutical Services Inc | 4.08 | 136M | Healthcare |
Agilent Technologies Inc | 3.90 | 131M | Healthcare |
Boston Scientific Corp | 3.85 | 129M | Healthcare |
10x Genomics Inc Ordinary Shares - Class A | 3.73 | 125M | Healthcare |
Abbott Laboratories | 3.46 | 116M | Healthcare |
Stryker Corp | 3.19 | 107M | Healthcare |